What is the current MEA Cancer Vaccines Market size?

The MEA Cancer Vaccines Market is projected to register a CAGR of 9.60% during the forecast period (2024-2029) Read More

Who are the key players in MEA Cancer Vaccines Market?

AstraZeneca PLC, Merck & Co. Inc., Bristol-Myers Squibb, Astellas Pharma Inc. and GSK plc are the major companies operating in the MEA Cancer Vaccines Market. Read More

What years does this MEA Cancer Vaccines Market cover?

The report covers the MEA Cancer Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the MEA Cancer Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

MEA Cancer Vaccines Market Size & Share Analysis - Industry Research Report

Middle-East and Africa Cancer Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Middle East and Africa Cancer Vaccine Market is Segmented by Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines, and Other Technologies), Treatment Method (Preventive Vaccine and Therapeutic Vaccine), Application (Prostate Cancer, Cervical Cancer, and Other Applications) and Geography (GCC, South Africa, Rest of Middle East and Africa). The report offers the value (in USD million) for the above segments.

MEA Cancer Vaccines Industry Overview

The Middle East and African cancer vaccines market is fragmented with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the key players are Astellas Pharma Inc., AstraZeneca PLC, Merck & Co. Inc, GlaxoSmithKline, and Bristol-Myers Squibb.